UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
Provided By GlobeNewswire
Last update: Apr 22, 2025
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2025.
Read more at globenewswire.com
